Has Douglas Koppel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $75,076 in general payments to Douglas Koppel, MD across 969 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Koppel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Koppel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Koppel, MD

Procedural Dermatology · Metairie, LANPI 1376616409

Payments from drug & device makers

$75,076in general payments, 2019–2025

Across 969 payments — averaging $77.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$25K
Arcutis Biotherapeutics, Inc.$22K
Kowa Pharmaceuticals America, Inc.$8K
Johnson & Johnson$4K
AbbVie$2K
Sanofi$2K
plus $12K from 32 others

What the payments were for

Consulting fees$19,38826%
Speaking & faculty fees$31,70042%
Travel & lodging$6,1838%
Food & beverage$17,03923%
Education$7661%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	23	$25,446
Arcutis Biotherapeutics, Inc.	61	$21,637
Kowa Pharmaceuticals America, Inc.	6	$8,245
Johnson & Johnson	68	$3,935
AbbVie(2 entities)	152	$2,054
Sanofi	90	$1,653
Journey Medical Corporation	11	$1,558
Medimetriks Pharmaceuticals, Inc.	5	$1,334
Mayne Pharma Commercial LLC	109	$1,284
Pfizer	68	$1,152
Lilly USA, LLC	58	$1,128
UCB, Inc.	49	$938
Amgen	42	$635
Regeneron Healthcare Solutions, Inc.	25	$578
EPI Health, LLC	47	$477
LEO Pharma Inc.	21	$414
E.r. Squibb & Sons, L.L.C.	25	$374
Sun Pharmaceutical Industries Inc.	17	$354
Dermavant Sciences, Inc.	20	$311
Novartis	16	$286
Ortho Dermatologics, A Division Of Bausch Health US, LLC	12	$232
Almirall LLC	9	$182
Sanofi-aventis U.S. LLC	4	$159
Genentech USA, Inc.	6	$116
Revance Therapeutics, Inc.	2	$99
Boehringer Ingelheim	3	$85
VYNE Pharmaceuticals Inc.	4	$82
Organon	3	$54
Botanix SB Inc	1	$43
Incyte Corporation	2	$39
Dermira, Inc.	2	$38
Bristol Myers Squibb	2	$32
Hill Dermaceuticals, Inc.	1	$26
Organogenesis Inc.	1	$22
Promius Pharma LLC	1	$21
Verrica Pharmaceuticals Inc.	1	$18
Biofrontera Inc.	1	$18
Cipher Pharmaceuticals US LLC	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$166,698

Medicare patients

639

Services billed

2,781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	317	$8,044
Tacrolimus	24	$6,777
CiclopiroxCiclopirox Olamine	254	$5,225
Mometasone Furoate	236	$4,219
Ketoconazole	318	$3,575
Hydrocortisone	213	$2,988
Metronidazole	69	$2,920
Doxycycline Hyclate	169	$2,887
Ammonium Lactate	150	$2,552
Triamcinolone Acetonide	195	$2,451
Clindamycin Phosphate	84	$1,675
Finasteride	103	$1,577
Imiquimod	28	$1,060
ValacyclovirValacyclovir Hcl	61	$907
Ciclopirox	48	$886

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Metairie

William ColemanMetairie$2.4M
William ColemanMetairie$1M
Rene KoppelMetairie$6K
Carter PaddockMetairie$4K
Mary LupoNew Orleans$226K
Jack Murphyla Place$6K
Maurice VickBaton Rouge$5K
Gordon RussoGretna$3K
Michael LindleyNew Orleans$1K
Chad PratherBaton Rouge$1K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →